-
Mashup Score: 3Pharmalittle: We're reading about Medicare and obesity drugs, GSK asthma inhalers, and more - 2 month(s) ago
The Congressional Budget Office forecast that Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years.”
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Medicare and obesity drugs, GSK asthma inhalers & More news.. https://t.co/tbO4Ndgq5H #pharma #PBM #obesity #weightloss #asthma #Medicare #insulin #Alzheimers $NVO $LLY $SNY $CVS $UNH $CI $MRK $GSK $ESAIY